Repeat Emergency Department Visits Among Patients With Asthma and COPD

Asthma Clinical Trial

Official title:

Repeat Emergency Department Visits Among Patients With Asthma and COPD

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02499887
• Other study ID #: 754754
• Status: Terminated
• Phase: N/A
• Start date: January 2016
• Est. completion date: September 2016

Study information

• Verified date: June 2019
• Source: State University of New York at Buffalo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency department to home. The investigators hypothesize that patients treated with inhaled corticosteroids in addition to oral corticosteroids and albuterol will have lower rates of 30-day return visits to the emergency department than those patients treated with oral corticosteroids and albuterol only.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 6
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Treated in the ED at the Erie County Medical Center (ECMC) for acute symptoms of asthma or COPD during the study period

• Patient age = 18 years

• Resident of the City of Buffalo or Erie County

• Discharged to home

• Patient expresses willingness to return to ECMC or own primary care provider for follow-up visits

• Able to provide informed consent

• Able to comprehend English language

Exclusion Criteria:

• Received oral or inhaled corticosteroids in the week before ED presentation

• Presented to the ED primarily for prescription refills

• Complicated comorbid conditions (e.g. renal disease, cardiovascular disease, CHF, HIV)

• Admitted to ECMC or discharged to another facility

• Previously enrolled during a prior visit to the ED during the study period

• For female patients--pregnant or pregnancy status indeterminate

• Antibiotics are prescribed to treat current asthma/COPD exacerbation.

Related Conditions & MeSH terms

• Asthma
• COPD
• Emergencies

Intervention

Drug:
• beclamethasone dipropionate
Inhaler
• albuterol
Inhaler
• Prednisone
Oral corticosteroid

Locations

Country	Name	City	State
United States	Erie County Medical Center	Buffalo	New York

Sponsors (1)

Lead Sponsor	Collaborator
State University of New York at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of Subjects With a Return Visit to the ED Within 30 Days of ED Discharge	Subjects' medical records will be reviewed for the 30 day period following ED discharge to determine if they return to the treating ED or another regional ED for treatment of an acute asthma/COPD exacerbation. Regional ED records will be queried by use of data maintained by HEALTHeLINK, our regional health information organization system. This will allow for more complete capture of ED return visits that could be obtained by looking only at a single ED.	30 days